Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.
Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C. Vissers MFJM, et al. Among authors: atassi n. Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1. Clin Transl Sci. 2022. PMID: 35649245 Free PMC article. Clinical Trial.
ALSUntangled No. 16: cannabis.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 Jun;13(4):400-4. doi: 10.3109/17482968.2012.687264. Amyotroph Lateral Scler. 2012. PMID: 22632446 Review. No abstract available.
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease.
Delnomdedieu M, Duvvuri S, Li DJ, Atassi N, Lu M, Brashear HR, Liu E, Ness S, Kupiec JW. Delnomdedieu M, et al. Among authors: atassi n. Alzheimers Res Ther. 2016 Mar 1;8(1):12. doi: 10.1186/s13195-016-0177-y. Alzheimers Res Ther. 2016. PMID: 26925577 Free PMC article. Clinical Trial.
ALSUntangled No. 8: Low dose naltrexone for ALS.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21. Amyotroph Lateral Scler. 2011. PMID: 21174518 No abstract available.
ALSUntangled No. 11: Nu Tech Mediworld.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jul;12(4):309-11. doi: 10.3109/17482968.2011.589205. Amyotroph Lateral Scler. 2011. PMID: 21702736 No abstract available.
ALSUntangled No. 28: Acupuncture.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):286-9. doi: 10.3109/21678421.2015.1039240. Epub 2015 May 11. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25960084 No abstract available.
ALSUntangled No. 14: Mototab.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 Jan;13(1):161-4. doi: 10.3109/17482968.2012.645410. Amyotroph Lateral Scler. 2012. PMID: 22214359
ALS Untangled No. 21: Fecal transplants.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):482-5. doi: 10.3109/21678421.2013.814981. Epub 2013 Jul 22. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23870000 Review. No abstract available.
130 results